VAN NOSTRAND ROBERT L

Average Profitability
35.53%
Insider Buys Quantity
2
Insider Buys Sum
$31,391.20
Insider Sells Quantity
4
Insider Sells Sum
$5.24M

Insider Activity of VAN NOSTRAND ROBERT L

According to the SEC Form 4 filings, VAN NOSTRAND ROBERT L, being in a position of

  1. director at Intra-Cellular Therapies, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 40000 shares for $2.98M,
    over all time since 2017-12-29, has bought 690 shares for $9,991, and sold 78500 shares for $5.24M.

The largest purchase of all time was on 2012-11-30 and amounted to 20000 shares of Yield10 Bioscience, Inc. for $21,400.

The largest sale of all time was on 2022-08-11 and amounted to 28500 shares of Intra-Cellular Therapies, Inc. for $1.63M.

Biography of VAN NOSTRAND ROBERT L

No biography is available at this moment.

2024-06-18SaleIntra-Cellular Therapies, Inc.
ITCI
director
20,000
0.0208%
$75.91$1.52M+1.46%
2024-02-27SaleIntra-Cellular Therapies, Inc.
ITCI
director
20,000
0.0206%
$72.93$1.46M+0.47%
2023-04-17SaleIntra-Cellular Therapies, Inc.
ITCI
director
10,000
0.0105%
$63.00$630,000-0.85%
2022-08-11SaleIntra-Cellular Therapies, Inc.
ITCI
28,500
0.0302%
$57.15$1.63M-9.06%
2017-12-29PurchaseIntra-Cellular Therapies, Inc.
ITCI
director
690
0.0015%
$14.48$9,991+35.53%
2012-11-30PurchaseYield10 Bioscience, Inc.
YTEN
director
20,000
0.0552%
$1.07$21,400+34.51%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.